CSL Behring
π§πͺBelgium
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
Phase 3
Completed
- Conditions
- Immune Thrombocytopenic Purpura
- Interventions
- Biological: Immunoglobulin Intravenous (Human)
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-11-23
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 58
- Registration Number
- NCT00168038
- Locations
- π·πΊ
Study Site (21), St. Petersburg, Russian Federation
πΊπ¦Study Site (02), Kyiv, Ukraine
πΊπ¦Study Site (03), Kyiv, Ukraine
Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks
Phase 2
Completed
- Conditions
- Hereditary Angioedema
- Interventions
- Biological: C1 Esterase InhibitorBiological: Placebo
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- CSL Behring
- Target Recruit Count
- 126
- Registration Number
- NCT00168103
- Locations
- π·πΊ
Study Site 1, Moscow, Russian Federation
π·πΊStudy Site 2, Moscow, Russian Federation
π·πΊStudy Site 3, Moscow, Russian Federation
Β© Copyright 2025. All Rights Reserved by MedPath